Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up
- PMID: 14675175
- DOI: 10.1046/j.1523-1747.2003.12620.x
Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up
Abstract
This study analyzes the suppression of sweat gland activity by botulinum toxin type B. We injected botulinum toxin type B (between 2 and 1000 mouse units subcutaneously) in the lateral side of both lower legs in 15 healthy volunteers. Sweat tests were carried out before botulinum toxin type B injections, and at 3 wk, 3 mo, and 6 mo. We studied focal anhidrosis by iodine-starch staining and by capacitance hygrometry after carbachol iontophoresis, according to the quantitative sudomotor axon reflex test (QSART). Iodine starch staining indicated that a threshold dose of 8 mouse units botulinum toxin type B leads to anhidrotic skin spots (>4 cm2) after 3 wk. Duration of anhidrosis was prolonged for 3 mo when 15 mouse units and for 6 mo when 125 mouse units botulinum toxin type B were injected. The size of the anhidrotic area decreased with time (p<0.001), indicating partial recovery at the edges. After 3 wk, the QSART score had significantly decreased to 18% of baseline and had decreased to zero in most subjects with doses of 62.5 mouse units or more. After 3 mo, the QSART had returned to 91% of baseline in all but one subject and, after 6 mo, recovery of sudomotor function was complete. Analysis by iodine-starch staining and QSART indicated that botulinum toxin type B suppresses sudomotor function effectively, in a concentration-dependent manner.
Similar articles
-
Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.Auton Neurosci. 2005 Feb 7;117(2):120-6. doi: 10.1016/j.autneu.2004.11.005. Auton Neurosci. 2005. PMID: 15664565 Clinical Trial.
-
Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry.Br J Dermatol. 2001 Jan;144(1):111-7. doi: 10.1046/j.1365-2133.2001.03961.x. Br J Dermatol. 2001. PMID: 11167691
-
Somatotopic arrangement of sudomotor axon reflex sweating in humans.Auton Neurosci. 2005 Dec 30;123(1-2):76-81. doi: 10.1016/j.autneu.2005.08.004. Epub 2005 Sep 27. Auton Neurosci. 2005. PMID: 16194630 Clinical Trial.
-
Dose-dependent anhidrotic effect of botulinum toxin.Curr Probl Dermatol. 2002;30:131-40. doi: 10.1159/000060686. Curr Probl Dermatol. 2002. PMID: 12471707 Review. No abstract available.
-
Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.Clin Dermatol. 2004 Jan-Feb;22(1):40-4. doi: 10.1016/j.clindermatol.2003.12.029. Clin Dermatol. 2004. PMID: 15158544 Review.
Cited by
-
In vivo release of non-neuronal acetylcholine from the human skin as measured by dermal microdialysis: effect of botulinum toxin.Br J Pharmacol. 2006 Jan;147(2):183-7. doi: 10.1038/sj.bjp.0706451. Br J Pharmacol. 2006. PMID: 16273117 Free PMC article.
-
Sudomotor dysfunction in diabetic peripheral neuropathy (DPN) and its testing modalities: A literature review.Heliyon. 2023 Jul 11;9(7):e18184. doi: 10.1016/j.heliyon.2023.e18184. eCollection 2023 Jul. Heliyon. 2023. PMID: 37539131 Free PMC article. Review.
-
Management of hyperhidrosis.Clin Cosmet Investig Dermatol. 2014 Oct 29;7:285-99. doi: 10.2147/CCID.S53119. eCollection 2014. Clin Cosmet Investig Dermatol. 2014. PMID: 25378942 Free PMC article. Review.
-
[Effect of botulinum toxin type B on residual limb sweating and pain. Is there a chance for indirect phantom pain reduction by improved prosthesis use?].Schmerz. 2012 Apr;26(2):176-84. doi: 10.1007/s00482-011-1140-2. Schmerz. 2012. PMID: 22527647 German.
-
Treatment of compensatory hyperhidrosis after sympathectomy with botulinum toxin and anticholinergics.Clin Auton Res. 2015 Jun;25(3):161-7. doi: 10.1007/s10286-015-0278-x. Epub 2015 Mar 14. Clin Auton Res. 2015. PMID: 25773586
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources